Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI

Clinical Research in Cardiology

Volumn 100, Issue 6, 2011, Pages 501-510

  Klug, Gert ^a   Mayr, Agnes ^a   Mair, Johannes ^a   Schocke, Michael ^a   Nocker, Michael ^a   Trieb, Thomas ^a   Jaschke, Werner ^a   Pachinger, Otmar ^a   Metzler, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cardiac magnetic resonance; Creatine kinase; Myocardial infarction; Primary PCI; Troponin

Indexed keywords

CREATINE KINASE; GADOLINIUM PENTETATE; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CREATINE KINASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 80051664646     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0273-0     Document Type: Article

References (40)

1. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ (1995) Infarct size after acute myocardial infarction measured by quantitative tomographic 99mtc sestamibi imaging predicts subsequent mortality. Circulation 92(3):334-341
2. Becker LC, Silverman KJ, Bulkley BH, Kallman CH, Mellits ED, WeisfeldtM(1983) Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation 67(6):1272-1282 (Pubitemid 13105350)
3. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS (2004) The quantification of infarct size. J Am Coll Cardiol 44(8):1533-1542. doi: 10.1016/j.jacc.2004.06.071 (Pubitemid 39377707)
4. Ibrahim T, Nekolla SG, Hornke M, Bulow HP, Dirschinger J, Schomig A, Schwaiger M (2005) Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with singlephoton emission tomography using tc99m-sestamibi. J Am Coll Cardiol 45(4):544-552. doi:10.1016/j.jacc.2004.10.058 (Pubitemid 40222249)
5. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G (2006) Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 47(8):1641-1645. doi:10.1016/j.jacc.2005.11.065
6. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100(19):1992-2002 (Pubitemid 29529292)
7. Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, Gibler WB, Stebbins AL, Cianciolo C, Califf RM, Topol EJ (1999) Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. Gustoiii investigators. Global use of strategies to open occluded coronary arteries. Am J Cardiol 84(11):1281-1286
8. James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, Simoons ML, Topol EJ, Venge P, Wallentin L (2003) Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a Gusto-IV Substudy. J Am Coll Cardiol 41(6): 916-924. doi:S0735109702029698[pii] (Pubitemid 36315530)
9. Savonitto S, Granger CB, Ardissino D, Gardner L, Cavallini C, Galvani M, Ottani F, White HD, Armstrong PW, Ohman EM, Pieper KS, Califf RM, Topol EJ (2002) The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. J Am Coll Cardiol 39(1):22-29. doi: S0735109701017065[pii] (Pubitemid 34059857)
10. Nienhuis MB, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, van't Hof AW (2008) Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am Heart J 155(4):673-679. doi: S0002-8703(07)00909-X[pii]10.1016/j.ahj.2007.11.004
11. Grande P, Hansen BF, Christiansen C, Naestoft J (1982) Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation 65(4):756-764 (Pubitemid 12133240)
12. Metzler B, Hammerer-Lercher A, Jehle J, Dietrich H, Pachinger O, Xu Q, Mair J (2002) Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin Chim Acta 325(1-2):87-90. doi:S0009898102002966[pii] (Pubitemid 35279629)
13. Cummins B, Cummins P (1987) Cardiac specific troponin-i release in canine experimental myocardial infarction: development of a sensitive enzyme-linked immunoassay. J Mol Cell Cardiol 19(10):999-1010. doi:S0022-2828(87)80572-2[pii] (Pubitemid 18015336)
14. Costa TN, Cassaro Strunz CM, Nicolau JC, Gutierrez PS (2008) Comparison of MB fraction of creatine kinase mass and troponin I serum levels with necropsy findings in acute myocardial infarction. Am J Cardiol 101(3):311-314. doi:S0002-9149(07)01911-X[pii]10.1016/j.amjcard.2007.08.037 (Pubitemid 351162963)
15. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W (2002) Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart 87(6):520-524 (Pubitemid 34547973)
16. Tzivoni D, Koukoui D, Guetta V, Novack L, Cowing G (2008) Comparison of troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol 101(6):753-757. doi:S0002-9149(07)02221-7[pii]10.1016/ j.amjcard.2007.09.119
17. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1(4):415-423. doi:S1936-8798(08)00254-9[pii]10.1016/j.jcin.2008.04.010
18. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (spect) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361(9355):374-379. doi:S0140-6736(03)12389-6[pii]10.1016/S0140-6736(03)12389-6 (Pubitemid 36164969)
19. Steen H, Futterer S, Merten C, Junger C, Katus HA, Giannitsis E (2007) Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. J Cardiovasc Magn Reson 9(5):749-758. doi:782025879[pii]10.1080/10976640701544589 (Pubitemid 47463901)
20. Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA (2006) Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 48(11):2192-2194. doi:S0735-1097(06)01459-8[pii]10.1016/j.jacc.2006.06.002 (Pubitemid 44855412)
21. Haase J, Bayar R, Hackenbroch M, Storger H, Hofmann M, Schwarz CE, Reinemer H, Schwarz F, Ruef J, Sommer T (2004) Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol 17(6): 367-373. doi:JOIC4078[pii]10.1111/j.1540-8183.2004.04078.x (Pubitemid 39552591)
22. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA (2008) Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 51(3):307-314. doi: S0735-1097(07)03442-0[pii]10.1016/j.jacc.2007.09.041
23. Bohmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S (2009) Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months. Cardiology 113(3):207-212. doi:00020199[pii]10.1159/000201991
24. Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36(3):959-969. doi: S0735109700008044[pii]
25. Mayr A, Mair J, Schocke M, Klug G, Pedarnig K, Haubner BJ, Nowosielski M, Grubinger T, Pachinger O, Metzler B (2009) Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function. Int J Cardiol. doi: 10.1016/j.ijcard.2009.09.537
26. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300(6719):230-235 (Pubitemid 20045528)
27. Klug G, Trieb T, Schocke M, Nocker M, Skalla E, Mayr A, Nowosielski M, Pedarnig K, Bartel T, Moes N, Pachinger O, Metzler B (2009) Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 29(2):298-304. doi:10.1002/jmri.21498
28. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG, Visser CA, van Rossum AC (2003) Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 42(5):895-901. doi:S0735109703008350 (Pubitemid 37059750)
29. Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC (2005) Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrastenhanced CMR. J Cardiovasc Magn Reson 7(2):481-485 (Pubitemid 40563339)
30. Nowosielski M, Schocke M, Mayr A, Pedarnig K, Klug G, Kohler A, Bartel T, Muller S, Trieb T, Pachinger O, Metzler B (2009) Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction. J Cardiovasc Magn Reson 11(1):22.doi:1532-429X- 11-22[pii]10.1186/1532-429X-11-22
31. Gallegos RP, Swingen C, Xu XJ, Wang X, Bianco R, Jerosch-Herold M, Bolman RM 3rd (2004) Infarct extent by MRI correlates with peak serum troponin level in the canine model. J Surg Res 120(2):266-271. doi:10.1016/j.jss.2004.02.025 (Pubitemid 38834195)
32. Kurz K, Schild C, Isfort P, Katus HA, Giannitsis E (2009) Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction. Clin Res Cardiol 98(2):94-100. doi:10.1007/s00392-008-0727-9
33. Kelle S, Roes SD, Klein C, Kokocinski T, de Roos A, Fleck E, Bax JJ, Nagel E (2009) Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 54(19):1770-1777. doi:S0735-1097(09)02668-0
34. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14): 1309-1321. doi:10.1056/ NEJMoa030207NEJMoa030207[pii] (Pubitemid 36384098)
35. Rasoul S, Nienhuis MB, Ottervanger JP, Slingerland RJ, de Boer MJ, Dambrink JH, Ernst NM, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van 't Hof AW (2006) Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction. Ann Clin Biochem 43(Pt 4):281-286. doi:10.1258/000456306777695627 (Pubitemid 44049691)
36. Panteghini M, Bonetti G, Pagani F, Stefini F, Giubbini R, Cuccia C (2005) Measurement of troponin I 48 h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction. Clin Chem Lab Med 43(8):848-854. doi:10.1515/CCLM.2005.143 (Pubitemid 41461161)
37. Apple FS, Sharkey SW, Falahati A, Murakami M, Mitha N, Christensen D (1998) Assessment of left ventricular function using serum cardiac troponin I measurements following myocardial infarction. Clin Chim Acta 272(1):59-67. doi: S0009898197002520[pii] (Pubitemid 28179617)
38. Adams JE 3rd, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodor GS, Ladenson JH, Jaffe AS (1994) Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 330(10):670-674 (Pubitemid 24066983)
39. Suessenbacher A, Doerler J, Alber H, Aichinger J, Altenberger J, Benzer W, Christ G, Globits S, Huber K, Karnik R, Norman G, Siostrzonek P, Zenker G, Pachinger O, Weidinger F (2008) Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: Data from the Austrian Acute PCI Registry. EuroIntervention 4(2):271-276
40. Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, Sabatine MS, Rifai N, Giugliano RP, DiBattiste PM, Demopoulos LA, Antman EM, Braunwald E (2004) Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: A Tactics-TIMI 18 (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18) substudy. Circulation 109(5):580-586. doi:10.1161/01.CIR.0000109491.66226.26109/ 5/580[pii] (Pubitemid 38198864)